Topic: Cancer research
Professor McCaughan’s team will test two potential new treatments which target HCC liver cancer cells.
This project will advance the understanding of how prostate cancer progresses and could lead to a new much-needed diagnostic approach.
Prof Gottardo will test a new treatment they hope will provide the answer to minimising devastating side effects of medulloblastoma treatment.
This project could significantly improve outcomes for patients with late-stage bowel cancer.
Dr Michelle McDonald and her team are in a unique position to examine how some drugs help to keep cancer cells in bone at bay.
Dr O’Reilly hopes the team’s work will lead to direct improvements on the quality of life and survival outcomes for stomach cancer patients.
Over 62 million deaths could be averted if HPV vaccination, cervical screening and access to cancer treatment services can be rapidly scaled by worldwide.
Cancer Council NSW researchers have investigated if testing bowel cancer cases is a cost-effective way of revealing undiagnosed Australians with Lynch syndrome.
This project has worked to improve treatments and reduce the major challenge of some breast cancer patients’ resistance to endocrine therapy and relapse.
Dr Micklethwaite has been developing myeloma-specific CAR T-cells – immune cells specifically designed to recognise and destroy myeloma cells.